Enhanced Dispersibility and Deposition of Spray-dried Powders for Pulmonary Gene Therapy

References

• Allison, S.D. and Anchordoquy, T.J. (2000) “Mechanisms of protection of cationic lipid-DNA complexes during lyophilisation”, J. Pharm. Sci. 89, 682–691.
   PubMed Web of Science ®Google Scholar
• Allison, S.D., Molina, M.C. and Anchordoquy, T.J. (2000) “Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis”, Biochim. Biophys. Acta 1468, 127–138.
   PubMed Web of Science ®Google Scholar
• Alton, E.W.F.W., Geddes, D.M., Gill, D.R., Higgins, C.F., Hyde, S.C., Innes, J.A. and Porteus, D.J. (1998) “Towards gene therapy for cystic fibrosis: a clinical progress report”, Gene Ther. 5, 291–292.
   PubMed Web of Science ®Google Scholar
• Anchordoquy, T.J., Allison, S.D., Molina, M.D.C., Girouard, L.G. and Carson, T.K. (2001) “Physical stabilization of DNA-based thera- peutics”, Drug Discov. Today 6, 463–470.
   PubMed Web of Science ®Google Scholar
• el-Araud, K.A., Clark, B.J., Kaahwa, C., Anum, P. and Chrystyn, H. (1998) “The effect of dose on the characterization of aerodynamic particle-size distributions of beclomethasone dipropionate metered- dose inhalers”, J. Pharm. Pharmacol. 50, 1081–1085.
   PubMed Web of Science ®Google Scholar
• Birchall, J.C., Kellaway, I.W. and Mills, S.N. (1999) “Physico-chemical characterization and transfection efficiency of lipid-based gene delivery complexes”, Int. J. Pharm. 183, 195–207.
   PubMed Web of Science ®Google Scholar
• Birchall, J.C., Kellaway, I.W. and Gumbleton, M. (2000) “Physical stability and in vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes”, Int. J. Pharm. 197, 221–231.
   PubMed Web of Science ®Google Scholar
• de Boer, A.H., Hagedoorn, P., Gjaltema, D., Goede, J., Kussendrager, K.D. and Frijlink, H.W. (2003) “Air classifier technology (ACT) in dry powder inhalation. Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation”, Int. J. Pharm. 260, 201–216.
   PubMed Web of Science ®Google Scholar
• Byron, P.R. (1986) “Some future perspectives for unit dose inhalation aerosol”, Drug Dev. Ind. Pharm. 12, 993–1015.
   Web of Science ®Google Scholar
• Chan, H.K. and Gonda, I. (1998) “Solid state characterization of spray dried powders of recombinant human deoxyribonuclease (rhDNase)”, J. Pharm. Sci. 87, 647–654.
   PubMed Web of Science ®Google Scholar
• Chan, L.W., Lim, L.T. and Heng, P.W. (2003) “Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations”, J. Pharm. Sci. 92, 975–984.
   PubMed Web of Science ®Google Scholar
• Chavan, V. and Dalby, R. (2002) “Novel system to investigate the effects of inhaled volume and rates of rise in simulated inspiratory air flow on fine particle output from a dry powder inhaler”, APS Pharm. Sci. 4, E6.
   Google Scholar
• Courrier, H.M., Butz, N. and Vandamme, T.F. (2002) “Pulmonary drug delivery systems: recent developments and prospects”, Crit. Rev. Ther. Drug Carrier Syst. 19, 425–498.
   PubMed Web of Science ®Google Scholar
• Dunbar, C., Scheuch, G., Sommerer, K., DeLong, M., Verma, A. and Batycky, R. (2002) “In vitro and in vivo dose delivery characteristics of large porous particles for inhalation”, Int. J. Pharm. 245, 179–189.
   PubMed Web of Science ®Google Scholar
• Durrani, M., Fitch, W., Fok, K., Radhakrishnan, R. and Ustter, P.S. (1991) Direct spray-dried drug/lipid powder composition. WO 91/16882.
   Google Scholar
• Forrester, R.B. and Boardman, T.D. (1986) Inhalation pharmaceuticals. US 4590206.
   Google Scholar
• Gao, X. and Huang, L. (1996) “Potentiation of cationic liposome- mediated gene delivery by polycations”, Biochemistry 35, 1027–1036.
   PubMed Web of Science ®Google Scholar
• Hickey, A.J. (1993) “Lung deposition and clearance of pharmaceutical serosol: what can be learned from inhalation toxicology and industrial hygiene?”, Aerosol Sci. Tech. 18, 290–304.
   Web of Science ®Google Scholar
• Iida, K., Hayakawa, Y., Okamoto, H., Danjo, K. and Leuenberger, H. (2003) “Preparation of dry powder inhalation by surface treatment of lactose carrier particles”, Chem. Pharm. Bull. 51, 1–5.
   PubMed Web of Science ®Google Scholar
• Johnson, K.A. (1997) “Preparation of peptide and protein powders for inhalation”, Adv. Drug Del. Rev. 26, 3–15.
   PubMed Web of Science ®Google Scholar
• Karhu, M., Kuikka, J., Kauppinen, T., Bergstrom, K. and Vidgren, M. (2000) “Pulmonary deposition of lactose carriers used in inhalation powders”, Int. J. Pharm. 196, 95–103.
   PubMed Web of Science ®Google Scholar
• Kuo, J.H. (2002) “The effect of protective agents on the stability of plasmid DNA by the process of spray-drying”, J. Pharm. Pharmacol. 55, 301–306.
   Web of Science ®Google Scholar
• Larhrib, H., Martin, G.P., Marriott, C. and Prime, D. (2003a) “The influence of carrier and drug morphology on drug delivery from dry powder formulations”, Int. J. Pharm. 257, 283–296.
   PubMed Web of Science ®Google Scholar
• Larhrib, H., Martin, G.P., Prime, D. and Marriott, C. (2003b) “Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers”, Eur. J. Pharm. Sci. 19, 211–221.
   PubMed Web of Science ®Google Scholar
• Li, S. and Huang, L. (1997) “In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes”, Gene Ther. 4, 891–900.
   PubMed Web of Science ®Google Scholar
• Li, S., Rizzo, M.A., Bhattacharya, S. and Huang, L. (1998) “Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery”, Gene Ther. 5, 930–937.
   PubMed Web of Science ®Google Scholar
• Li, B., Li, S., Tan, Y., Stolz, D.B., Watkins, S.C., Block, L.H. and Huang, L. (2000) “Lyophilization of cationic lipid-protamine-DNA (LPD) complexes”, J. Pharm. Sci. 89, 355–364.
   PubMed Web of Science ®Google Scholar
• Lucas, P., Anderson, K., Potter, U.J. and Staniforth, J.N. (1999) “Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive”, Pharm. Res. 16, 1643–1647.
   PubMed Web of Science ®Google Scholar
• Maa, Y.F., Nguyen, P.A., Andya, J.D., Dasovich, N., Sweeney, T.D., Shire, S.J. and Hsu, C.C. (1998) “Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders”, Pharm. Res. 15, 768–775.
   PubMed Web of Science ®Google Scholar
• Millqvist-Fureby, A., Malmsten, M. and Bergenstahl, B. (1999) “Surface characterization of freeze-dried protein/carbohydrate mixtures”, Int. J. Pharm. 191, 103–114.
   PubMed Web of Science ®Google Scholar
• Pikal, M.J. (1990) “Freeze-drying of proteins. Part 1: process design”, Biopharmacy 9, 18–27.
   Google Scholar
• Selam, J.L. (2003) “Inhaled insulin for the treatment of diabetes: projects and devices”, Expert Opin. Pharmacother. 4, 1373–1377.
   PubMed Web of Science ®Google Scholar
• Seville, P.C., Kellaway, I.W. and Birchall, J.C. (2002) “Preparation of dry powder dispersions for non-viral gene delivery by freeze-drying and spray-drying”, J. Gene Med. 4, 428–437.
   PubMed Web of Science ®Google Scholar
• Seville, P.C., Kellaway, I.W. and Birchall, J.C. (2003) “Stability, deposition and biological functionality of non-viral gene delivery vectors for pulmonary administration”, J. Control Release, Proceedings of the 7th European Symposium on Controlled Drug Delivery.
   Google Scholar
• Sheng, S.H. and Scheule, R.K. (1998) “Airway delivery of cationic lipid: DNAcomplexes for cystic fibrosis”, Adv. Drug Deliv. Rev. 30, 173–184.
   PubMed Web of Science ®Google Scholar
• Sorgi, F.L., Bhatacharya, S. and Huang, L. (1997) “Protamine sulfate enhances lipid-mediated gene transfer”, Gene Ther. 4, 961–968.
   PubMed Web of Science ®Google Scholar
• Steckel, H. and Muller, B.W. (1998) “Metered-dose inhaler add-on devices: an in vitro evaluation of the BronchoAir inhaler and several spacer devices”, J. Aerosol Med. 11, 133–142.
   PubMedGoogle Scholar
• Talsma, H., Cherng, J.Y., Lehrmann, H., Kursa, M., Ogris, M., Hennink, W.E., Cotton, M. and Wagner, E. (1997) “Stablization of gene delivery systems by freeze-drying”, Int. J. Pharm. 157, 233–238.
   PubMed Web of Science ®Google Scholar
• Tzannis, S.T. and Prestrelski, S.J. (1999) “Activity-stability consider- ations of trypsinogen during spray drying: effects of sucrose”, J. Pharm. Sci. 88, 351–359.
   PubMed Web of Science ®Google Scholar
• Vile, R. and Russell, S.J. (1994) “Gene transfer technologies for the gene therapy of cancer”, Gene Ther. 1, 88–98.
   PubMed Web of Science ®Google Scholar
• Weda, M., Zanen, P., de Boer, A.H., Gjaltema, D., Ajaoud, A., Barends, D.M. and Frijlink, H.W. (2002) “Equivalence testing of salbutamol dry powder inhalers: in vitro impaction results versus in vivo efficacy”, Int. J. Pharm. 249, 247–255.
   PubMedGoogle Scholar
• Wolfenden, R., Andersson, L., Cullis, P. and Southgate, C. (1981) “Affinities of amino acid side chains for solvent water”, Biochemistry 20, 849–855.
   PubMed Web of Science ®Google Scholar